FASLG and neoplasm: sFas and/or sFasL has been identified the association with tumor, coronary artery disease, rheumatic disease, and other diseases (Sahinarslan et al., 2012; Adly et al., 2016; Chiloff et al., 2020; Vincent et al., 2020).